BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15334204)

  • 1. Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels.
    Gomes SA; Lage A; Lazaretti-Castro M; Vieira JG; Heilberg IP
    Braz J Med Biol Res; 2004 Sep; 37(9):1379-88. PubMed ID: 15334204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
    Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
    Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative characteristics of diagnostic methods of primary hyperparathyroidism in patients with urolithiasis].
    Ismailov SI; Uzbekov KK; Gaĭbullaev AA; Alimzhanov NA; Nasirov AA; Babakhanov BKh
    Urologiia; 2002; (6):8-11. PubMed ID: 12577570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia.
    Gunn IR; Wallace JR
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():52-8. PubMed ID: 1536526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?].
    Gardin JP; Houillier P; Borensztein P; Paillard M
    Nephrologie; 1991; 12(2):71-7. PubMed ID: 1944759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test.
    Hagag P; Revet-Zak I; Hod N; Horne T; Rapoport MJ; Weiss M
    J Endocrinol Invest; 2003 Apr; 26(4):327-32. PubMed ID: 12841540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
    Maruani G; Hertig A; Paillard M; Houillier P
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
    Ahrén B; Bergenfelz A
    Horm Res; 1995; 43(6):294-9. PubMed ID: 7607615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism.
    Monchik JM; Lamberton RP; Roth U
    Surgery; 1992 Dec; 112(6):1103-9; discussion 1109-10. PubMed ID: 1455312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
    Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
    Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ionized calcium and parathyroid hormone in renal stone disease.
    Muldowney FP; Freaney R; McMullin JP; Towers RP; Spillane A; O'Connor P; O'Donohoe P; Moloney M
    Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of parathyroid hormone secretion by EDTA infusion--a test for the differential diagnosis of hypercalcaemia.
    Benson L; Rastad J; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):498-506. PubMed ID: 3085418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism.
    McLeod MK; Monchik JM; Martin HF
    Surgery; 1984 Jun; 95(6):667-73. PubMed ID: 6729704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperparathyroidism: clinical and laboratory spectrum].
    Heilberg IP; Ramos OL; Schor N
    Rev Paul Med; 1989; 107(4-6):212-8. PubMed ID: 2640506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
    Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
    Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.